IP Library Granted Patent US 9,764,009
Granted Patent B2
US 9,764,009 · App. 13/495,605 · Granted Sep 19, 2017

Treatment of psychological trauma

Inventors: Kenton B. Abel (Hacienda Heights, CA); Andrew M. Blumenfeld (Del Mar, CA)
Assignee: Allergan, Inc.
A61K38/4893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,764,009
App. No.
13/495,605
Granted
Sep 19, 2017
Kind
B2
Abstract

The present specification discloses methods of treating a psychological trauma in an individual using botulinum toxins and/or a Targeted Exocytosis Modulator, and compositions thereof.

Claims (2)

1. A method of treating at least one symptom of post-traumatic stress disorder in a patient in need thereof, the method comprising the step of administering to the patient a therapeutically effective amount of a composition including a botulinum neurotoxin serotype A (BoNT/A), wherein administration is to the glabellar complex; wherein administration of the composition decreases the at least one symptom of the post-traumatic stress disorder; and wherein the at least one symptom of post-traumatic stress disorder comprises total or partial amnesia of a traumatic event, flashbacks or nightmares wherein the patient re-experiences the traumatic event, avoidance of stimuli associated with the traumatic event, increased arousal including difficulty falling or staying asleep, anger, hyper-vigilance, or combinations thereof.

2. The method of claim 1 , wherein the composition is additionally administered to: the frontalis at divided among four sites of administration; to the occipitalis at six sites to eight sites of administration; to the temporalis at eight sites to ten sites of administration; to the trapezius at six sites to ten sites of administration and to the cervical paraspinal muscles at four sites of administration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2012
From: ABEL, KENTON B.; BLUMENFELD, ANDREW M.
To: ALLERGAN, INC.
Reel/Frame 028657/0486 →
Continuity (2)
Provisional Application 61496192 · Jun 13, 2011
Related Publication 20120315297A1 · Dec 13, 2012